9-2039776-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBA1

The NM_003070.5(SMARCA2):​c.705_707delGCA​(p.Gln236del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.146 in 1,427,642 control chromosomes in the GnomAD database, including 5,709 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2394 hom., cov: 26)
Exomes 𝑓: 0.14 ( 3315 hom. )

Consequence

SMARCA2
NM_003070.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.00

Publications

9 publications found
Variant links:
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
SMARCA2 Gene-Disease associations (from GenCC):
  • intellectual disability-sparse hair-brachydactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003070.5
BP6
Variant 9-2039776-ACAG-A is Benign according to our data. Variant chr9-2039776-ACAG-A is described in ClinVar as Benign. ClinVar VariationId is 126353.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.351 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003070.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA2
NM_003070.5
MANE Select
c.705_707delGCAp.Gln236del
disruptive_inframe_deletion
Exon 4 of 34NP_003061.3
SMARCA2
NM_001289396.2
c.705_707delGCAp.Gln236del
disruptive_inframe_deletion
Exon 4 of 34NP_001276325.1
SMARCA2
NM_139045.4
c.705_707delGCAp.Gln236del
disruptive_inframe_deletion
Exon 4 of 33NP_620614.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA2
ENST00000349721.8
TSL:5 MANE Select
c.705_707delGCAp.Gln236del
disruptive_inframe_deletion
Exon 4 of 34ENSP00000265773.5
SMARCA2
ENST00000382203.5
TSL:1
c.705_707delGCAp.Gln236del
disruptive_inframe_deletion
Exon 4 of 34ENSP00000371638.1
SMARCA2
ENST00000450198.6
TSL:1
c.705_707delGCAp.Gln236del
disruptive_inframe_deletion
Exon 4 of 33ENSP00000392081.2

Frequencies

GnomAD3 genomes
AF:
0.165
AC:
24790
AN:
150198
Hom.:
2377
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.0375
Gnomad AMR
AF:
0.142
Gnomad ASJ
AF:
0.0833
Gnomad EAS
AF:
0.365
Gnomad SAS
AF:
0.183
Gnomad FIN
AF:
0.162
Gnomad MID
AF:
0.0865
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.143
GnomAD4 exome
AF:
0.143
AC:
183010
AN:
1277344
Hom.:
3315
AF XY:
0.144
AC XY:
90470
AN XY:
627376
show subpopulations
African (AFR)
AF:
0.233
AC:
7052
AN:
30264
American (AMR)
AF:
0.207
AC:
7439
AN:
35932
Ashkenazi Jewish (ASJ)
AF:
0.0978
AC:
1997
AN:
20410
East Asian (EAS)
AF:
0.354
AC:
11364
AN:
32122
South Asian (SAS)
AF:
0.183
AC:
12195
AN:
66666
European-Finnish (FIN)
AF:
0.192
AC:
8255
AN:
42888
Middle Eastern (MID)
AF:
0.0889
AC:
426
AN:
4794
European-Non Finnish (NFE)
AF:
0.127
AC:
126434
AN:
993810
Other (OTH)
AF:
0.156
AC:
7848
AN:
50458
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
12023
24047
36070
48094
60117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5042
10084
15126
20168
25210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.165
AC:
24843
AN:
150298
Hom.:
2394
Cov.:
26
AF XY:
0.168
AC XY:
12320
AN XY:
73378
show subpopulations
African (AFR)
AF:
0.238
AC:
9714
AN:
40866
American (AMR)
AF:
0.143
AC:
2152
AN:
15100
Ashkenazi Jewish (ASJ)
AF:
0.0833
AC:
288
AN:
3458
East Asian (EAS)
AF:
0.365
AC:
1852
AN:
5080
South Asian (SAS)
AF:
0.183
AC:
860
AN:
4710
European-Finnish (FIN)
AF:
0.162
AC:
1669
AN:
10288
Middle Eastern (MID)
AF:
0.0793
AC:
23
AN:
290
European-Non Finnish (NFE)
AF:
0.118
AC:
7946
AN:
67510
Other (OTH)
AF:
0.146
AC:
305
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
939
1878
2818
3757
4696
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.106
Hom.:
12
Bravo
AF:
0.173

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 24, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Aug 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Dec 16, 2022
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Nicolaides-Baraitser syndrome;C5443984:Blepharophimosis-impaired intellectual development syndrome Benign:1
Mar 30, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.0
Mutation Taster
=79/21
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113070757; hg19: chr9-2039776; COSMIC: COSV61804479; COSMIC: COSV61804479; API